ArticleOncotarget2015

MCL-1-independent mechanisms of synergy between dual PI3K/mTOR and BCL-2 inhibition in diffuse large B cell lymphoma.

J Scott Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.